Report Details

Gamma valerolactone is colorless liquid. It is one of the more common lactones. GVL is chiral but is usually used as the racemate. It can be used to produce food flavors, used as solvent for resins, monomer intermediate, lubricant, plasticizer and so on.

Scope of the Report:

This report focuses on the Gamma Valerolactone (CAS 108-29-2) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Gamma valerolactone has been used in food flavors, solvent industry, as well as chemical synthesis and so on. Among various applications, food flavors accounts for the largest consumption share with 80.57% in 2017.

The gamma valerolactone industry is relatively small at the moment. There are only a few manufacturers engaged in the production. Manufacturers of Anhui Hyea gamma valerolactone mainly concentrate in China. Aromas is the largest producer of gamma valerolactone, owning 62% production share globally.

Consumption of gamma valerolactone mainly distribute in USA and China. USA imports gamma valerolactone from China to meet its demand. In 2017, 13.8 MT gamma valerolactone was consumed in USA while China consumed 29.81%.

The worldwide market for Gamma Valerolactone (CAS 108-29-2) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Anhui Hyea Aromas

Dideu Industries

Kunshan Qiandeng Baihua

Zhongyue Aroma

Soda Aromatic

Inoue Perfumery MFG

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Food Grade

Industrial Grade

Market Segment by Applications, can be divided into

Food Flavors

Solvent

Monomer Intermediate

Others

There are 15 Chapters to deeply display the global Gamma Valerolactone (CAS 108-29-2) market.

Chapter 1, to describe Gamma Valerolactone (CAS 108-29-2) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Gamma Valerolactone (CAS 108-29-2), with sales, revenue, and price of Gamma Valerolactone (CAS 108-29-2), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Gamma Valerolactone (CAS 108-29-2), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Gamma Valerolactone (CAS 108-29-2) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Gamma Valerolactone (CAS 108-29-2) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table Of Content

Table of Contents

1 Market Overview
    1.1 Gamma Valerolactone (CAS 108-29-2) Introduction
    1.2 Market Analysis by Type
        1.2.1 Food Grade
        1.2.2 Industrial Grade
    1.3 Market Analysis by Applications
        1.3.1 Food Flavors
        1.3.2 Solvent
        1.3.3 Monomer Intermediate
        1.3.4 Others
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2013-2023)
            1.4.1.2 Canada Market States and Outlook (2013-2023)
            1.4.1.3 Mexico Market States and Outlook (2013-2023)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2013-2023)
            1.4.2.2 France Market States and Outlook (2013-2023)
            1.4.2.3 UK Market States and Outlook (2013-2023)
            1.4.2.4 Russia Market States and Outlook (2013-2023)
            1.4.2.5 Italy Market States and Outlook (2013-2023)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2013-2023)
            1.4.3.2 Japan Market States and Outlook (2013-2023)
            1.4.3.3 Korea Market States and Outlook (2013-2023)
            1.4.3.4 India Market States and Outlook (2013-2023)
            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2013-2023)
            1.4.4.2 Egypt Market States and Outlook (2013-2023)
            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
            1.4.4.4 South Africa Market States and Outlook (2013-2023)
            1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Anhui Hyea Aromas
        2.1.1 Business Overview
            2.1.1.1 Anhui Hyea Aromas Description
            2.1.1.2 Anhui Hyea Aromas Headquarter, Main Business and Finance Overview
        2.1.2 Anhui Hyea Aromas Gamma Valerolactone (CAS 108-29-2) Product Introduction
            2.1.2.1 Gamma Valerolactone (CAS 108-29-2) Production Bases, Sales Regions and Major Competitors
            2.1.2.2 Gamma Valerolactone (CAS 108-29-2) Product Information
        2.1.3 Anhui Hyea Aromas Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.1.3.1 Anhui Hyea Aromas Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.1.3.2 Global Anhui Hyea Aromas Gamma Valerolactone (CAS 108-29-2) Market Share in 2017
    2.2 Dideu Industries
        2.2.1 Business Overview
            2.2.1.1 Dideu Industries Description
            2.2.1.2 Dideu Industries Headquarter, Main Business and Finance Overview
        2.2.2 Dideu Industries Gamma Valerolactone (CAS 108-29-2) Product Introduction
            2.2.2.1 Gamma Valerolactone (CAS 108-29-2) Production Bases, Sales Regions and Major Competitors
            2.2.2.2 Gamma Valerolactone (CAS 108-29-2) Product Information
        2.2.3 Dideu Industries Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.2.3.1 Dideu Industries Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.2.3.2 Global Dideu Industries Gamma Valerolactone (CAS 108-29-2) Market Share in 2017
    2.3 Kunshan Qiandeng Baihua
        2.3.1 Business Overview
            2.3.1.1 Kunshan Qiandeng Baihua Description
            2.3.1.2 Kunshan Qiandeng Baihua Headquarter, Main Business and Finance Overview
        2.3.2 Kunshan Qiandeng Baihua Gamma Valerolactone (CAS 108-29-2) Product Introduction
            2.3.2.1 Gamma Valerolactone (CAS 108-29-2) Production Bases, Sales Regions and Major Competitors
            2.3.2.2 Gamma Valerolactone (CAS 108-29-2) Product Information
        2.3.3 Kunshan Qiandeng Baihua Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.3.3.1 Kunshan Qiandeng Baihua Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.3.3.2 Global Kunshan Qiandeng Baihua Gamma Valerolactone (CAS 108-29-2) Market Share in 2017
    2.4 Zhongyue Aroma
        2.4.1 Business Overview
            2.4.1.1 Zhongyue Aroma Description
            2.4.1.2 Zhongyue Aroma Headquarter, Main Business and Finance Overview
        2.4.2 Zhongyue Aroma Gamma Valerolactone (CAS 108-29-2) Product Introduction
            2.4.2.1 Gamma Valerolactone (CAS 108-29-2) Production Bases, Sales Regions and Major Competitors
            2.4.2.2 Gamma Valerolactone (CAS 108-29-2) Product Information
        2.4.3 Zhongyue Aroma Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.4.3.1 Zhongyue Aroma Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.4.3.2 Global Zhongyue Aroma Gamma Valerolactone (CAS 108-29-2) Market Share in 2017
    2.5 Soda Aromatic
        2.5.1 Business Overview
            2.5.1.1 Soda Aromatic Description
            2.5.1.2 Soda Aromatic Headquarter, Main Business and Finance Overview
        2.5.2 Soda Aromatic Gamma Valerolactone (CAS 108-29-2) Product Introduction
            2.5.2.1 Gamma Valerolactone (CAS 108-29-2) Production Bases, Sales Regions and Major Competitors
            2.5.2.2 Gamma Valerolactone (CAS 108-29-2) Product Information
        2.5.3 Soda Aromatic Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.5.3.1 Soda Aromatic Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.5.3.2 Global Soda Aromatic Gamma Valerolactone (CAS 108-29-2) Market Share in 2017
    2.6 Inoue Perfumery MFG
        2.6.1 Business Overview
            2.6.1.1 Inoue Perfumery MFG Description
            2.6.1.2 Inoue Perfumery MFG Headquarter, Main Business and Finance Overview
        2.6.2 Inoue Perfumery MFG Gamma Valerolactone (CAS 108-29-2) Product Introduction
            2.6.2.1 Gamma Valerolactone (CAS 108-29-2) Production Bases, Sales Regions and Major Competitors
            2.6.2.2 Gamma Valerolactone (CAS 108-29-2) Product Information
        2.6.3 Inoue Perfumery MFG Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.6.3.1 Inoue Perfumery MFG Gamma Valerolactone (CAS 108-29-2) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.6.3.2 Global Inoue Perfumery MFG Gamma Valerolactone (CAS 108-29-2) Market Share in 2017
3 Global Gamma Valerolactone (CAS 108-29-2) Market Competition, by Manufacturer
    3.1 Global Gamma Valerolactone (CAS 108-29-2) Sales and Market Share by Manufacturer (2016-2017)
    3.2 Global Gamma Valerolactone (CAS 108-29-2) Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Global Gamma Valerolactone (CAS 108-29-2) Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Gamma Valerolactone (CAS 108-29-2) Manufacturer Market Share in 2017
        3.4.2 Top 5 Gamma Valerolactone (CAS 108-29-2) Manufacturer Market Share in 2017
    3.5 Market Competition Trend
4 Global Gamma Valerolactone (CAS 108-29-2) Market Analysis by Regions
    4.1 Global Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Regions
        4.1.1 Global Gamma Valerolactone (CAS 108-29-2) Sales by Regions (2013-2018)
        4.1.2 Global Gamma Valerolactone (CAS 108-29-2) Revenue by Regions (2013-2018)
    4.2 North America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Growth Rate (2013-2018)
    4.3 Europe Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Growth Rate (2013-2018)
    4.4 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Growth Rate (2013-2018)
    4.5 South America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Growth Rate (2013-2018)
    4.6 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Growth Rate (2013-2018)
5 North America Gamma Valerolactone (CAS 108-29-2) by Countries, Type, Application and Manufacturers
    5.1 North America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Countries
        5.1.1 North America Gamma Valerolactone (CAS 108-29-2) Sales by Countries (2013-2018)
        5.1.2 North America Gamma Valerolactone (CAS 108-29-2) Revenue by Countries (2013-2018)
        5.1.3 United States Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        5.1.4 Canada Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        5.1.5 Mexico Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
    5.2 North America Gamma Valerolactone (CAS 108-29-2) Sales and Revenue (Value) by Manufacturers (2016-2017)
        5.2.1 North America Gamma Valerolactone (CAS 108-29-2) Sales by Manufacturers (2016-2017)
        5.2.2 North America Gamma Valerolactone (CAS 108-29-2) Revenue by Manufacturers (2016-2017)
    5.3 North America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Type (2013-2018)
        5.3.1 North America Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Type (2013-2018)
        5.3.2 North America Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Type (2013-2018)
    5.4 North America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Application (2013-2018)
        5.4.1 North America Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Application (2013-2018)
        5.4.2 North America Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Application (2013-2018)
6 Europe Gamma Valerolactone (CAS 108-29-2) by Countries, Type, Application and Manufacturers
    6.1 Europe Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Countries
        6.1.1 Europe Gamma Valerolactone (CAS 108-29-2) Sales by Countries (2013-2018)
        6.1.2 Europe Gamma Valerolactone (CAS 108-29-2) Revenue by Countries (2013-2018)
        6.1.3 Germany Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        6.1.4 UK Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        6.1.5 France Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        6.1.6 Russia Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        6.1.7 Italy Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
    6.2 Europe Gamma Valerolactone (CAS 108-29-2) Sales and Revenue (Value) by Manufacturers (2016-2017)
        6.2.1 Europe Gamma Valerolactone (CAS 108-29-2) Sales by Manufacturers (2016-2017)
        6.2.2 Europe Gamma Valerolactone (CAS 108-29-2) Revenue by Manufacturers (2016-2017)
    6.3 Europe Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Type (2013-2018)
        6.3.1 Europe Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Type (2013-2018)
        6.3.2 Europe Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Type (2013-2018)
    6.4 Europe Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Application (2013-2018)
        6.4.1 Europe Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Application (2013-2018)
        6.4.2 Europe Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) by Countries, Type,  Application and Manufacturers
    7.1 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales by Countries (2013-2018)
        7.1.2 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Revenue by Countries (2013-2018)
        7.1.3 China Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        7.1.4 Japan Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        7.1.5 Korea Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        7.1.6 India Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        7.1.7 Southeast Asia Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
    7.2 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales and Revenue (Value) by Manufacturers (2016-2017)
        7.2.1 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales by Manufacturers (2016-2017)
        7.2.2 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Revenue by Manufacturers (2016-2017)
    7.3 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Type (2013-2018)
        7.3.1 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Type (2013-2018)
        7.3.2 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Type (2013-2018)
    7.4 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Application (2013-2018)
        7.4.1 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Application (2013-2018)
        7.4.2 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Application (2013-2018)
8 South America Gamma Valerolactone (CAS 108-29-2) by Countries, Type, Application and Manufacturers
    8.1 South America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Countries
        8.1.1 South America Gamma Valerolactone (CAS 108-29-2) Sales by Countries (2013-2018)
        8.1.2 South America Gamma Valerolactone (CAS 108-29-2) Revenue by Countries (2013-2018)
        8.1.3 Brazil Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        8.1.4 Argentina Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        8.1.5 Colombia Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
    8.2 South America Gamma Valerolactone (CAS 108-29-2) Sales and Revenue (Value) by Manufacturers (2016-2017)
        8.2.1 South America Gamma Valerolactone (CAS 108-29-2) Sales by Manufacturers (2016-2017)
        8.2.2 South America Gamma Valerolactone (CAS 108-29-2) Revenue by Manufacturers (2016-2017)
    8.3 South America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Type (2013-2018)
        8.3.1 South America Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Type (2013-2018)
        8.3.2 South America Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Type (2013-2018)
    8.4 South America Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Application (2013-2018)
        8.4.1 South America Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Application (2013-2018)
        8.4.2 South America Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) by Countries, Type, Application and Manufacturers
    9.1 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales by Countries (2013-2018)
        9.1.2 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Revenue by Countries (2013-2018)
        9.1.3 Saudi Arabia Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        9.1.4 UAE Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        9.1.5 Egypt Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        9.1.6 Nigeria Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
        9.1.7 South Africa Gamma Valerolactone (CAS 108-29-2) Sales and Growth Rate (2013-2018)
    9.2 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales and Revenue (Value) by Manufacturers (2016-2017)
        9.2.1 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales by Manufacturers (2016-2017)
        9.2.2 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Revenue by Manufacturers (2016-2017)
    9.3 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Type (2013-2018)
        9.3.1 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Type (2013-2018)
        9.3.1 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Type (2013-2018)
    9.4 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Application (2013-2018)
        9.4.1 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Sales and Sales Share by Application (2013-2018)
        9.4.2 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Revenue and Revenue Share by Application (2013-2018)
10 Global Gamma Valerolactone (CAS 108-29-2) Market Segment by Type
    10.1 Global Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Market Share by Type (2013-2018)
        10.1.1 Global Gamma Valerolactone (CAS 108-29-2) Sales and Market Share by Type (2013-2018)
        10.1.2 Global Gamma Valerolactone (CAS 108-29-2) Revenue and Market Share by Type (2013-2018)
    10.2 Food Grade Sales Growth and Price
        10.2.1 Global Food Grade Sales Growth (2013-2018)
        10.2.2 Global Food Grade Price (2013-2018)
    10.3 Industrial Grade Sales Growth and Price
        10.3.1 Global Industrial Grade Sales Growth (2013-2018)
        10.3.2 Global Industrial Grade Price (2013-2018)
11 Global Gamma Valerolactone (CAS 108-29-2) Market Segment by Application
    11.1 Global Gamma Valerolactone (CAS 108-29-2) Sales Market Share by Application (2013-2018)
    11.2 Food Flavors Sales Growth (2013-2018)
    11.3 Solvent Sales Growth (2013-2018)
    11.4 Monomer Intermediate Sales Growth (2013-2018)
    11.5 Others Sales Growth (2013-2018)
12 Gamma Valerolactone (CAS 108-29-2) Market Forecast (2018-2023)
    12.1 Global Gamma Valerolactone (CAS 108-29-2) Sales, Revenue and Growth Rate (2018-2023)
    12.2 Gamma Valerolactone (CAS 108-29-2) Market Forecast by Regions (2018-2023)
        12.2.1 North America Gamma Valerolactone (CAS 108-29-2) Market Forecast (2018-2023)
        12.2.2 Europe Gamma Valerolactone (CAS 108-29-2) Market Forecast (2018-2023)
        12.2.3 Asia-Pacific Gamma Valerolactone (CAS 108-29-2) Market Forecast (2018-2023)
        12.2.4 South America Gamma Valerolactone (CAS 108-29-2) Market Forecast (2018-2023)
        12.2.5 Middle East and Africa Gamma Valerolactone (CAS 108-29-2) Market Forecast (2018-2023)
    12.3 Gamma Valerolactone (CAS 108-29-2) Market Forecast by Type (2018-2023)
        12.3.1 Global Gamma Valerolactone (CAS 108-29-2) Sales Forecast by Type (2018-2023)
        12.3.2 Global Gamma Valerolactone (CAS 108-29-2) Market Share Forecast by Type (2018-2023)
    12.4 Gamma Valerolactone (CAS 108-29-2) Market Forecast by Application (2018-2023)
        12.4.1 Global Gamma Valerolactone (CAS 108-29-2) Sales Forecast by Application (2018-2023)
        12.4.2 Global Gamma Valerolactone (CAS 108-29-2) Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

Inquiry For Buying

(North America, Europe, Asia-Pacific, South America, Middle East and Africa) Gamma Valerolactone (CAS 108-29-2) Market

Please fill out the form. We will contact you within 24 hours:
All fields required...

Request Sample

(North America, Europe, Asia-Pacific, South America, Middle East and Africa) Gamma Valerolactone (CAS 108-29-2) Market

Please fill out the form. We will contact you within 24 hours:
All fields required...

×

Avail PDF Sample Report

Thank you for contacting us.

Thank you for your interest in our research report.

We will be sending you the sample copy of the report shortly. Meanwhile, if you have any specific research requirement then please let us know. We will be glad to assist you in case you have any additional questions, so feel free to get in touch

Thank you


Warm regards,
Sales | Manager - International Business and partner Relations
Direct line: +1 347 535 0815
Market Research Store
E-mail: sales@MarketResearchStore.com | Web: www.MarketResearchStore.com